Literature DB >> 10367434

Developments in cardiovascular ultrasound. Part 3: Cardiac applications.

C M Moran1, W N McDicken, P R Hoskins, P J Fish.   

Abstract

Echocardiography is still the principal, non-invasive method of investigation for the evaluation of cardiac disorders. Using Doppler ultrasound, indices such as coronary flow reserve and cardiac output can be determined. The severity of valvular stenosis can be determined by the area of the valve, either directly from 2D echo, from pressure half-time calculations, from continuity equations or from the proximal isovelocity surface area method. Alternatively, the severity of regurgitation can be estimated by colour or pulsed ultrasound detection of the back-projection of the high-velocity jet into the chamber. Myocardial wall abnormalities can be assessed using 2D ultrasound, M-mode or analysis from the radio-frequency-ultrasound signal. Doppler tissue imaging can be used to quantify intra-myocardial wall velocities, and 3D reconstruction of cardiac images can provide visualisation of the complete cardiac anatomy from any orientation. The development of myocardial contrast agents and associated imaging techniques to enhance visualisation of these agents within the myocardium has aided qualitative assessment of myocardial perfusion abnormalities. However, quantitative myocardial perfusion has still to be realised.

Entities:  

Mesh:

Year:  1998        PMID: 10367434     DOI: 10.1007/bf02524420

Source DB:  PubMed          Journal:  Med Biol Eng Comput        ISSN: 0140-0118            Impact factor:   2.602


  103 in total

1.  Estimation of left ventricular cavity area with an on-line, semiautomated echocardiographic edge detection system.

Authors:  B F Vandenberg; L S Rath; P Stuhlmuller; H E Melton; D J Skorton
Journal:  Circulation       Date:  1992-07       Impact factor: 29.690

Review 2.  Contrast echocardiography 1996. A review.

Authors:  H R Villarraga; D A Foley; S L Mulvagh
Journal:  Tex Heart Inst J       Date:  1996

3.  Doppler tissue imaging: myocardial wall motion velocities in normal subjects.

Authors:  P Palka; A Lange; A D Fleming; G R Sutherland; L N Fenn; W N McDicken
Journal:  J Am Soc Echocardiogr       Date:  1995 Sep-Oct       Impact factor: 5.251

Review 4.  Developments in cardiovascular ultrasound: Part 1: Signal processing and instrumentation.

Authors:  P J Fish; P R Hoskins; C Moran; W N McDicken
Journal:  Med Biol Eng Comput       Date:  1997-11       Impact factor: 2.602

5.  Influence of data processing on cyclic variation of integrated backscatter and wall thickness in stunned porcine myocardium.

Authors:  A F van der Steen; H Rijsterborgh; C T Lancee; F Mastik; R Krams; P D Verdouw; J R Roelandt; N Bom
Journal:  Ultrasound Med Biol       Date:  1997       Impact factor: 2.998

6.  A system for ultrasonically imaging the human heart in three dimensions.

Authors:  D L Dekker; R L Piziali; E Dong
Journal:  Comput Biomed Res       Date:  1974-12

7.  Three-dimensional colour Doppler imaging.

Authors:  P A Picot; D W Rickey; R Mitchell; R N Rankin; A Fenster
Journal:  Ultrasound Med Biol       Date:  1993       Impact factor: 2.998

8.  Two-dimensional echocardiographic assessment of mitral stenosis.

Authors:  P M Nichol; B W Gilbert; J A Kisslo
Journal:  Circulation       Date:  1977-01       Impact factor: 29.690

9.  Measurement of left ventricular ejection fraction by acoustic quantification and comparison with radionuclide angiography.

Authors:  K J Yvorchuk; R A Davies; K L Chan
Journal:  Am J Cardiol       Date:  1994-11-15       Impact factor: 2.778

10.  A new method for noninvasive quantification of valvular regurgitation based on conservation of momentum. In vitro validation.

Authors:  E G Cape; E G Skoufis; A E Weyman; A P Yoganathan; R A Levine
Journal:  Circulation       Date:  1989-06       Impact factor: 29.690

View more
  1 in total

Review 1.  Developments in cardiovascular ultrasound. Part 2: Arterial applications.

Authors:  P R Hoskins; P J Fish; W N McDicken; C Moran
Journal:  Med Biol Eng Comput       Date:  1998-05       Impact factor: 2.602

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.